Misoprostol alone for early medical abortion in a Latin American clinic setting.
Misoprostol is being used widely by women throughout Latin America, often based on instructions passed along through friends, acquaintances or professionals who may have little information about safe and effective use. This paper presents the experience of a Latin American clinic working in a legally restrictive setting that offers misoprostol as one option to women seeking early pregnancy termination. Between February 2001 and June 2002, 3225 women who attended the clinic chose to use misoprostol rather than vacuum aspiration. 89.9% returned for follow-up, of whom 76.4% had had a complete abortion within 72 hours, using one, two or three doses of 800 micrograms of misoprostol administered by the woman herself vaginally every 24 hours. The first 78 women who returned for follow-up at 72 hours responded to a questionnaire regarding their experiences. Satisfaction with the abortion process was high, despite some pain, chills, diarrhoea and/or nausea. Seventy-two of the 78 women said they would use misoprostol again if they needed to terminate another pregnancy and would recommend it to a friend. Having a clinic where staff are knowledgeable and experienced in misoprostol use is particularly important in settings where abortion is stigmatised, unsafe abortion common and access to safe services limited.
Billings
Deborah L
DL
Senior Associate, Research and Evaluation, Ipas Mexico, Mexico City, Mexico. debbieb@ipas.org.mx
D000020:Abortifacient Agents, Nonsteroidal; D000028:Abortion, Induced / Q000331:legislation & jurisprudence; D000293:Adolescent; D000328:Adult; D000554:Ambulatory Care Facilities; D002985:Clinical Protocols; D005260:Female; D006801:Humans; D007843:Latin America; D016595:Misoprostol / Q000008:administration & dosage*; D011247:Pregnancy; D011253:Pregnancy in Adolescence
D000020:Abortifacient Agents, Nonsteroidal; D016595:Misoprostol